Oct 8 (Reuters) - U.S. FDA:
* FDA SAYS IS REISSUING MAY 26, 2021 LETTER IN ITS ENTIRETY, TO REFLECT THAT DISTRIBUTION OF AUTHORIZED SOTROVIMAB WILL BE CONTROLLED BY U.S. GOVERNMENT Source text for Eikon: Further company coverage:
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.255 USD | +8.19% | +3.84% | -17.94% |
Oct 8 (Reuters) - U.S. FDA:
* FDA SAYS IS REISSUING MAY 26, 2021 LETTER IN ITS ENTIRETY, TO REFLECT THAT DISTRIBUTION OF AUTHORIZED SOTROVIMAB WILL BE CONTROLLED BY U.S. GOVERNMENT Source text for Eikon: Further company coverage:
1st Jan change | Capi. | |
---|---|---|
-17.94% | 1.04B | |
+2.06% | 42.59B | |
+8.24% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-24.41% | 18.17B | |
+29.21% | 12.05B | |
-2.54% | 11.7B | |
+6.98% | 11.1B |